Dr. Wooldridge is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Checkmate Pharmaceuticals
Cambridge, MA 02142- Is this information wrong?
Education & Training
University of Iowa Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1996 - 1999- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1992 - 1996
Tulane University School of MedicineClass of 1992
Certifications & Licensure
MO State Medical License 1999 - 2025
Publications & Presentations
PubMed
- 57 citationsOvercoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma.Antoni Ribas, Theresa Medina, John M. Kirkwood, Yousef Zakharia, Rene Gonzalez, Diwakar Davar, Bartosz Chmielowski, Katie M. Campbell, Riyue Bao, Heather Kelley, Aaron...> ;Cancer Discovery. 2021 Jul 29
- 45 citationsA first-in-human phase I study of a bivalent MET antibody, emibetuzumab (LY2875358), as monotherapy and in combination with erlotinib in advanced cancerLee S. Rosen, Jonathan W. Goldman, Alain Algazi, P. Kellie Turner, Brian A. Moser, Tianle Hu, Xuejing Aimee Wang, Jay Tuttle, Volker Wacheck, James E. Wooldridge, Mich...> ;Clinical Cancer Research. 2017 Apr 15
- 35 citationsPhase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myelomaNoopur Raje, Philippe Moreau, Evangelos Terpos, Lotfi Benboubker, Norbert Grząśko, Sarah A. Holstein, Albert Oriol, Shang-Yi Huang, Meral Beksac, Kazimierz Kuliczkowsk...> ;British Journal of Haematology. 2017 Mar 1
- Join now to see all
Press Mentions
Immunitas Therapeutics Announces First Patient Dosed in Phase 1/2a Study of IMT-009January 4th, 2023
Checkmate Pharmaceuticals Announces Additions to Management TeamOctober 15th, 2019
Grant Support
- CPG 7909 In Previously Treated Chronic Lymphocytic LeukemiaNational Center For Research Resources2005–2006
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
